参芪养心颗粒联合运动康复对冠心病PCI术后患者的疗效观察

参芪养心颗粒联合运动康复对冠心病PCI术后患者的疗效观察【摘要】目的：探讨参芪养心颗粒联合运动康复对冠心病经皮冠状动脉介入术（PCI）术后患者的疗效。方法：选取2018年1月至2020年1月期间，在我院接受PCI治疗的冠心病患者60例，随机分为两组，对照组30例给予常规药物治疗及康复训练，实验组30例在常规治疗基础上加用参芪养心颗粒和运动康复。比较两组治疗后的心绞痛发作次数、生活质量评分以及血脂水平的变化。结果：实验组患者在心绞痛发作次数、生活质量评分以及血脂水平方面均优于对照组，差异具有统计学意义（P<0.05）。结论：参芪养心颗粒联合运动康复可显著提高冠心病PCI术后患者的生活质量，减少心绞痛发作，改善血脂水平，值得临床推广应用。【关键词】冠心病；PCI；参芪养心颗粒；运动康复；疗效观察【Abstract】Objective:ToinvestigatethetherapeuticeffectofShenqiYangxinGranulecombinedwithexerciserehabilitationonpatientswithcoronaryheartdiseaseafterPCI.Methods:Atotalof60patientswithcoronaryheartdiseasewhoreceivedPCItreatmentinourhospitalfromJanuary2018toJanuary2020wereselectedandrandomlydividedintotwogroups,with30casesineachgroup.Thecontrolgroupwastreatedwithconventionalmedicationandrehabilitationtraining,whiletheexperimentalgroupwasgivenShenqiYangxinGranuleandexerciserehabilitationinadditiontotheconventionaltreatment.Thefrequencyofanginaattacks,qualityoflifescores,andbloodlipidlevelswerecomparedbetweenthetwogroupsaftertreatment.Results:Theexperimentalgrouphadfeweranginaattacks,higherqualityoflifescores,andimprovedbloodlipidlevelsthanthecontrolgroup,withstatisticaldifferences(P<0.05).Conclusion:ShenqiYangxinGranulecombinedwithexerciserehabilitationcansignificantlyimprovethequalityoflifeofpatientswithcoronaryheartdiseaseafterPCI,reducethefrequencyofanginaattacks,andimprovebloodlipidlevels,whichisworthclinicalpromotionandapplication.【Keywords】Coronaryheartdisease;PCI;ShenqiYangxinGranule;Exerciserehabilitation;Therapeuticeffectobservation銆怉bstract銆慭nObjective:ToinvestigatethetherapeuticeffectofShenqiYangxinGranulecombinedwithexerciserehabilitationonpatientswithcoronaryheartdiseaseafterPCI.Methods:Atotalof60patientswithcoronaryheartdiseasewhoreceivedPCItreatmentinourhospitalfromJanuary2018toJanuary2020wereselectedandrandomlydividedintotwogroups,with30casesineachgroup.Thecontrolgroupwastreatedwithconventionalmedicationandrehabilitationtraining,whiletheexperimentalgroupwasgivenShenqiYangxinGranuleandexerciserehabilitationinadditiontotheconventionaltreatment.Thefrequencyofanginaattacks,qualityoflifescores,andbloodlipidlevelswerecomparedbetweenthetwogroupsaftertreatment.Results:Theexperimentalgrouphadfeweranginaattacks,higherqualityoflifescores,andimprovedbloodlipidlevelsthanthecontrolgroup,withstatisticaldifferences(P<0.05).Conclusion:ShenqiYangxinGranulecombinedwithexerciserehabilitationcansignificantlyimprovethequalityoflifeofpatientswithcoronaryheartdiseaseafterPCI,reducethefrequencyofanginaattacks,andimprovebloodlipidlevels,whichisworthclin